Klinisol Privacy & Policy
Last Updated: September 29th 20201. Introduction
(i) These terms and conditions shall govern your use of our mobile application.
(ii) By using our mobile application, “you” - the user, accepts these terms and conditions in full.
(iii) If you register and access our mobile application, you are hereby asked to fully agree to these terms and conditions.
2. Mobile Application
(i) Klinisol is the exclusive owner of its mobile application Klinisol eConsent.
3. Study Content and Ownership Data
(i) All sponsor study content, including but not limiting to sponsor logo, study design, study documents, study video’s, general study content, study contacts, study vendors and community postings are owned exclusively by the sponsor.
(ii) All study content and documents within Klinisol eConsent must be treated as Confidential Information.
4. Study Content and Document Use
(i) Any and all study specific content and documents may only be used for the specific study that it assigned to and intended by the sponsor.
(ii) You may not use study content, documents, forms, etc. from one study for another study.
5. Contact Information for Personnel and Vendors
(i) The contact information posting within Klinisol and its mobile application Klinisol eConsent for personnel and vendors shall be deemed as confidential and as such is required to be treated as confidential information.
6. Data Collection
(i) Klinisol may collect your behavior information to help improve the usability, functionality and general content within the application.
(ii) Klinisol may also share aggregated user app usage and utilization data with sponsor.
(iii) Data may also be shared with third parties, including but not limiting to law enforcement and Federal Drug Administration, if required.
7. Account Termination
(i) Klinisol and Sponsor reserve the right to cancel your study account at any time without prior notification.
(ii) Your study account and access to study content and documents shall terminate upon study completion